| 摘要 |
The present invention relates to a pharmaceutical composition for treating a neoplasm, a preneoplasm, a proliferative disorder and/or a precancerous lesion, the use of such compositions for the treatment of the listed conditions, and methods of treating the listed conditions. The composition of the present invention comprises an inhibitor of elF4E, a methyltransferase inhibitor, and a pharmaceutically acceptable carrier.
|
